
Enable Medicine: A biotech firm streamlining drug development through innovative cloud-based spatial biology data analysis.
Enable Medicine, founded in 2019 by Aaron Mayer and Sunil Bodapati in Menlo Park, California, is a biotechnology company focused on accelerating drug development through advanced spatial biology data analysis. The company's core mission is to streamline the discovery of biological insights by leveraging their cloud-based platform, which integrates AI/ML research and spatial methods. Their services include generating, managing, and analyzing various biological image formats, providing a collaborative ecosystem for researchers to run experiments, decrease costs, and accelerate time to insight.
Notable affiliated individuals include co-founders Aaron Mayer and Sunil Bodapati. Enable Medicine has made significant strides in the biotech industry by offering a comprehensive cloud biodata infrastructure that empowers high-stakes drug research and development. Their platform's ability to index and analyze vast multimodal data has led to actionable biological insights, making a substantial impact on the efficiency and effectiveness of therapeutic breakthroughs.

Enable Therapeutics

Enable
enableglobal.io

Generate Biomedicines

Enable Biosciences

Endpoint Health

Benchling
benchling.com

Insitro
insitro.com

Medable
medable.com

PipeBio

Superluminal Medicines
superluminalrx.com

Faze Medicines
fazemed.com

Known Medicine

Insilico Medicine
insilico.com

Valo Health
valohealth.com

Biodock
biodock.ai
Companies similar to Enable Medicine include Enable Therapeutics, Enable, Generate Biomedicines and Enable Biosciences.
Enable Medicine was founded in 2019.
Enable Medicine's headquarters is located in Menlo Park, CA, US.
Enable Medicine's most recent funding round was for $60M (USD) in April 2022.
As of Apr 21, 2022, Enable Medicine has raised a total of $63.6M (USD).
Enable Medicine has 50 employees as of Feb 5, 2024.